Clinical Trials

The Canadian Cancer Trials Group (CCTG) supports national and international multicentre phase I-III cancer clinical research trials aimed at improving the survival and quality of life of cancer patients across all cancer types. The scientific agenda for the group is developed by clinical researchers across Canada and beyond, includes trials of new cancer agents, novel radiation and surgical techniques, as well as interventions to improve patient quality of life.

If you are a CCTG member and need to access the full trials pages please click here.

The links below will take you to pages that list all the current CCTG trials with a brief description. If you are interested in volunteering for a trial we suggest that you discuss the opportunity with your care team.

If you are a patient or caregiver and are looking for other information about clinical trials a complete listing of clinical trials being conducted in Canada, including the locations where they are being conducted, can be found here: Canadian Cancer Trials.  And if you are interested in learning about participating in a clinical trial more information can be found here:



Dr. Solar Vasconcelos awarded the Frances A Shepherd Award

Dr. Joao Paulo Solar Vasconcelos receives the Frances A Shepherd Award

Congratulations to Dr. Vasconcelos, a BC Cancer GI Medical Oncology Fellow, was selected by the CCTG review committee to be awarded the The Frances A Shepherd Award for his abstract: Transverse colon primary analysis for CO20 and CO17 which was selected for the ASCO Gastrointestinal Cancers Symposium.

More >>
Oral presentation by Dr Laura Dawson at the ASCO Gastrointestinal Cancer Symposium 2023 of results for the Canadian Cancer Trials Group (CCTG) HE1

Quality of life study shows radiation can improve pain management for liver cancer patients

Oral presentation by Dr Laura Dawson at the ASCO Gastrointestinal Cancer Symposium 2023 of results for the CCTG HE1 phase III study of palliative radiation therapy for symptomatic hepatocellular carcinoma and liver metastases.

More >>
EN10 A gynecological cancer clinical trial

CCTG EN10 study is tailoring therapy for post-surgical patients with low-risk endometrial cancer

EN10 (RAINBO BLUE & TAPER) is a new Canadian clinical trial that is applying state-of-the-art molecular testing to classify post-surgery treatments in early-stage endometrial cancer to identify people at low risk of cancer recurrence based on the molecular features of their tumours.

More >>
SPECT-CT Guided ELEctive Contralateral Neck Treatment (Select) for Patients with Lateralized Oropharyngeal Cancer.

Now open, the HN11 SELECT trial looking at a personalized radiotherapy treatment for throat cancer

CCTG HN11 SELECT has now opened to accrual across Canada and sites in the US. The trial is a randomized, controlled, phase III clinical trial for patients with lateralized oropharyngeal carcinoma (OPC)

More >>